MSCRF Validation Program
Forecasted
The MSCRF Validation Program by TEDCO funds Maryland academic teams to validate and advance human stem cell technologies toward commercial use.
Funder: Maryland Technology Development Corporation (TEDCO)
Due Dates (Anticipated): January 2027 (Mid-January Cycle) | June 2027 (Mid-July Cycle)
Funding Amounts: Up to $250,000 per award (2 years); up to $350,000 with Second-tier Funding; indirect costs capped at 15%.
Summary: Supports Maryland faculty in validating and commercializing human stem cell technologies with strong market potential.
Key Information: Only Maryland-based university/research institute faculty (not federal labs) are eligible as PI.
Description
This program accelerates the transition of innovative human stem cell technologies from Maryland academic institutions into the commercial sector. It funds validation and market assessment activities—helping teams establish the commercial feasibility of their technologies, strengthen intellectual property, and advance toward licensing or start-up formation. The program encourages collaborations between Maryland universities and businesses, aiming to address unmet medical needs and boost the state's biotechnology sector.
